Cargando…
Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Liver Cancer Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035738/ https://www.ncbi.nlm.nih.gov/pubmed/37383406 http://dx.doi.org/10.17998/jlc.2022.09.20 |
| _version_ | 1784911476854620160 |
|---|---|
| author | Lee, Hye Won |
| author_facet | Lee, Hye Won |
| author_sort | Lee, Hye Won |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10035738 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Liver Cancer Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100357382023-06-28 Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? Lee, Hye Won J Liver Cancer Editorial The Korean Liver Cancer Association 2022-09 2022-09-29 /pmc/articles/PMC10035738/ /pubmed/37383406 http://dx.doi.org/10.17998/jlc.2022.09.20 Text en Copyright © 2022 The Korean Liver Cancer Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Lee, Hye Won Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title | Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title_full | Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title_fullStr | Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title_full_unstemmed | Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title_short | Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? |
| title_sort | is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis c virus-related hepatocellular carcinoma? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035738/ https://www.ncbi.nlm.nih.gov/pubmed/37383406 http://dx.doi.org/10.17998/jlc.2022.09.20 |
| work_keys_str_mv | AT leehyewon isdirectactingantiviraltreatmentbeneficialorharmfulforpatientswithhepatitiscvirusrelatedhepatocellularcarcinoma |